What is a medspa GLP-1 program in Scottsdale, AZ?
A medspa GLP-1 program is a prescription weight loss service that a medical spa adds to its treatment menu, typically featuring compounded semaglutide or tirzepatide prescribed through telehealth. For medspas in Scottsdale, AZ, the program runs under your existing brand: clients complete an online intake, meet with a provider licensed in Arizona by video, and receive medication from an FDA-registered 503A or 503B pharmacy if it is clinically appropriate. Telehealth Grow supplies the provider network, pharmacy connections, consent templates, EMR and subscription billing, so your team does not need to hire a medical director solely for weight loss. The result is a recurring monthly revenue line that pairs naturally with body contouring, skin tightening and wellness treatments you already offer.
Why Scottsdale is a strong market for a medspa GLP-1 program
With an estimated 243,006 residents (U.S. Census Bureau, 2025), Scottsdale is the 7th largest city in Arizona. It sits inside the Phoenix–Mesa–Chandler, AZ metropolitan area, which has roughly 5,228,938 residents.
The population has been broadly stable since 2020 (+0.7%), so growth here comes from winning share of an established market. Brand trust, convenience and patient retention matter more than simply being first.
Scottsdale is spread out — roughly 1,312 residents per square mile across 184 square miles. When patients face long drives between appointments, a telehealth-first GLP-1 program removes one of the biggest reasons people stop treatment.
Scottsdale accounts for about 5% of its metro population, and its +0.7% change since 2020 is slower than Arizona as a whole (+6.6%). That makes it one of several demand centers in the region, so a telehealth brand that serves the whole metro captures far more patients than a single storefront.
Your patient base can extend well beyond Scottsdale. Within driving distance are Phoenix, AZ (15 miles, 1.7M residents), Tempe, AZ (20 miles, 191K residents), Mesa, AZ (21 miles, 514K residents) and Glendale, AZ (22 miles, 261K residents), and telehealth lets one brand serve every one of them.
In Arizona, 29.5% of adults were living with obesity in 2020 CDC Behavioral Risk Factor Surveillance System (BRFSS) data — below the median across U.S. states of 31.3%. Applied to Scottsdale’s adult population, that suggests roughly 55,900 adults who could be candidates for a GLP-1 conversation with a licensed provider.
The West has some of the lowest obesity prevalence in CDC data, so brands here win by pairing GLP-1 care with fitness, nutrition and longevity goals rather than selling weight loss alone.
For medspas and aesthetic practices in Scottsdale, that combination of population, health need and telehealth convenience is exactly why a medspa GLP-1 program can build recurring monthly revenue quickly.
| Population (2025 est.) | 243,006 |
|---|---|
| Change since 2020 Census | +0.7% |
| Metro area | Phoenix–Mesa–Chandler, AZ (5.2M) |
| Population density | 1,312 per sq mi |
| Adult obesity rate (AZ, CDC BRFSS) | 29.5% |
| Estimated adults living with obesity | 55,900 |
| NP practice environment (AANP) | Full practice |
Arizona compliance snapshot for Scottsdale
A medspa GLP-1 program serving Scottsdale follows Arizona law. Three points matter most:
- Prescriber licensure: every patient located in Scottsdale must be treated by a clinician licensed in Arizona.
- Nurse practitioner rules: Arizona is a full practice state in AANP’s classification, which shapes how physician oversight is structured.
- Ownership: the MSO-PC model keeps the business you own separate from the licensed clinical practice.
Read the full Arizona medspa GLP-1 program guide for telehealth prescribing, compounding and advertising rules. Our compliance team verifies current requirements for your business during onboarding; this is general information, not legal advice.
Revenue potential in Scottsdale
Here is an illustrative projection. If a medspa GLP-1 program in Scottsdale reached just 0.25% of the adults estimated to be living with obesity, and each active patient generated about $120 in monthly profit (the benchmark used in our revenue calculator), the numbers would look like this:
| Adults living with obesity (est.) | 55,900 |
|---|---|
| Active patients at 0.25% reach | 140 |
| Estimated monthly profit | $16,800 |
| Estimated annual run rate | $201,600 |
Illustration only, not a guarantee. Actual revenue depends on medication costs, dosages, pricing, telehealth visit fees, marketing spend and patient retention.